Alpha fetoprotein (AFP) as a specific tumor marker not only plays an important role in the diagnosis of HCC, but also be used to assess tumor burden, which is why it is used to predict prognosis in patients with HCC after various treatments (4, 5). Here, AFP is linked to hepatocellular carcinoma.